All amounts in U.S. dollars unless otherwise indicated BROOKFIELD, News, Nov. 05, 2025 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) (“Brookfield Renewable Partners”, “BEP“) today reported financial results for the three and nine months ended September 30, 2025. “We had another strong quarter, advancing several strategic priorities while delivering strong financial results. In October, we announced a transformational partnership with the U.S. Government that should significantly accelerate deployment of Westinghouse’s leading reactor technology in the U.S. and abroad, which we expect to drive substantial growth for our business for years to come,” said Connor Teskey, CEO of Brookfield Renewable.  He continued, “We continued to extend our leadership position in essential baseload power...

For the three months ended September 30, 2025, from continuing operations:Revenues of $701.3 million GAAP net loss of $(15.9) million Adjusted EBITDA of $50.7 million GAAP and adjusted net (loss) income per diluted share of $(0.17) and $0.12, respectively Book-to-bill ratio of 1.13x, resulting in 1.07x book-to-bill for the trailing 12 months Cost saving initiatives remain on track Raising 2025 revenue guidance to a range of $2,700 million to $2,750 million; narrowing 2025 adjusted EBITDA guidance to a range of $175 million to $195 millionDURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the third quarter ended September 30, 2025. “Fortrea delivered a solid performance that met expectations in the...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map designed to accelerate treatments for a wide range of neurological diseases With this achievement, Recursion will have reached over $500 million in milestone and upfront payments across all its partnerships and collaborations Approximately $785 million of cash and cash equivalents (unaudited) as of October 9, 2025- runway through the end of 2027, without additional financingSALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its third quarter ended September 30, 2025. Recursion will host a (L)earnings Call on November 5, 2025...

Q3 2025 Financial Highlights Q3 revenue of $1.6 billion decreased 10% year-over-year and 14% on an organic basis Revenue growth of 14% excluding confidential contract; 9% on an organic basis Q3 net income of $64 million decreased $8 million year-over-year Q3 adjusted EBITDA decreased 5% to $158 million; adjusted EBITDA margin of 9.8% increased 60 basis points Book-to-bill ratio of 1.0x and continued streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since IPO Total backlog increased to $8.8 billion; 72% is funded, highest level since IPO Modifying fiscal year 2025 revenue and reiterating adjusted EBITDA and cash flow guidance ranges at mid-pointCHANTILLY, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) today announced financial results for the third quarter ended September 30, 2025. CEO...

Conference Call and Webcast Today at 8:30 a.m. ETPhase 2/3 OCU410ST GARDian3 pivotal confirmatory trial is progressing toward 1H 2027 Biologics License Application (BLA) filing with 50% enrollment completed to dateEuropean Medicines Agency (EMA) provided acceptability of a single U.S.-based trial for submission of a Marketing Authorization Application (MAA)Executed licensing agreement with Kwangdong Pharmaceutical for exclusive rights in South Korea to OCU400Sales milestones of $1.5 million for every $15 million of sales in South Korea, projected to reach $180 million or more in first 10 years of commercialization and royalties equaling 25% of net salesClosed $20 million registered direct offering of common stock and accompanying premium warrantsThe Company will receive $30 million of additional gross proceeds if the warrants...

Delivered Y/Y Net Sales Growth of 10.4%Drove Y/Y Bookings Growth in Engagement RingsAchieved 45% Y/Y Bookings Growth in Fine JewelryDelivered 57.6% Gross Margin SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced financial results for the three and nine months ended September 30, 2025. Third Quarter 2025 Highlights (quarterly period ended September 30, 2025):Delivered Third Quarter Net Sales of $110.3 million, a 10% year-over-year growth, exceeding the Company’s guidance rangeAchieved a return to year-over-year bookings growth in engagement rings with an increase in ASP quarter over quarter Delivered highest-ever wedding and anniversary band bookings with double-digit...

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC) today announced third quarter 2025 results from continuing operations. Third Quarter 2025 Financial Highlights:Sales of $678 million, a 15% decrease compared to the second quarter of 2025 Gross profit, as a percentage of sales, of 18.4% Adjusted Gross Profit, as a percentage of sales, of 21.8% Net loss from continuing operations of $9 million Adjusted EBITDA of $36 million, or 5.3% of sales Revenue backlog of $571 million, an increase of 4% compared to the same period last year (a 21% year-on-year increase in the U.S. segment backlog)Rob Saltiel, MRC Global’s President and CEO, commented, “The implementation of our new enterprise resource planning (ERP) system in our U.S. segment encountered significant challenges that adversely impacted our revenues, profitability,...

GOUVERNEUR, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX: TI, OTCQB: TIMCF(1)) (“Titan” or the “Company”), an existing zinc concentrate producer in upstate New York and an emerging natural flake graphite producer, a key component in the broader rare earths and critical minerals ecosystem, today announced strong financial and operational results for the three months ended September 30, 2025. HIGHLIGHTS(2): Operating and Financial Performance:Zinc production: 14.6 million payable pounds for the quarter, representing an increase of over 76% from Q3 2024; 45.5 million lbs year to date Revenues: $16.8 million, up 102% from Q3 2024   Cash Costs: C1 cash costs of $1.01/lb, (-23% YoY), AISC of $1.13/lb (-16% YoY) Operating cash flow: $5.0 million in Q3, $7.1 million year-to-date Safety: Continued strong safety...

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“TRGP,” the “Company” or “Targa”) today reported third quarter 2025 results. Third quarter 2025 net income attributable to Targa Resources Corp. was $478.4 million compared to $387.4 million for the third quarter of 2024. The Company reported adjusted earnings before interest, income taxes, depreciation and amortization, and other non-cash items (“adjusted EBITDA”)(1) of $1,274.8 million for the third quarter of 2025 compared to $1,069.7 million for the third quarter of 2024. HighlightsRecord adjusted EBITDA for the third quarter of $1.3 billion, a 19% increase year over year and a 10% increase compared to the second quarter Record Permian, NGL transportation, and fractionation volumes during the third quarter Repurchased approximately $156 million...

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced its results for the third quarter ended September 30, 2025. “We delivered another strong quarter with our third quarter results beating the high-end of our guidance across all metrics” said Adam Singolda, CEO of Taboola. “Realize is at an inflection point and driving meaningful success for our advertisers. We’re building on that momentum and are even more confident in our strategy. As a result, we’re continuing to aggressively buy back shares, having already repurchased 14% of the company this year.” Third Quarter 2025 Financial Results (All comparisons are to the third quarter of 2024 unless otherwise noted.)Revenues of $496.8 million, an increase of 14.7%. Revenues...